Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Colchicine in COVID-19
NCT04867226Phase 2Completed
- Sponsor
- Hawler Medical University
- Start
- May 2021
- Primary completion
- Jun 2021
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in coronavirus disease 2019 (COVID-19), sponsored by Hawler Medical University. Started May 2021; status: completed.
02
Drugs
colchicine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04867226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04867226.